US FDA accepts resubmitted NDA of Aldeyra Therapeutics for review of topical ocular reproxalap to treat dry eye disease: Lexington, Massachusetts Saturday, July 19, 2025, 13:00 Hr ...

"I may have been swayed if this represented a major advance in the field," said panelist Walter Dunn, MD, PhD, of the ...

Your morning coffee ritual is usually a simple pleasure, but a recent recall of certain coffee pods might make you ...